半乳糖凝集素1(GAL1)多克隆抗体(异硫氰酸荧光素标记)

FITC-Linked Polyclonal Antibody to Galectin 1 (GAL1)

LGALS1; GBP; HLBP14; Galaptin; Lectin,Galactoside-Binding Soluble 1; 14 kDa laminin-binding protein; Lactose-binding lectin 1; Putative MAPK-activating protein PM12; S-Lac lectin

  • 半乳糖凝集素1(GAL1)多克隆抗体(异硫氰酸荧光素标记) 产品包装(模拟)
  • 半乳糖凝集素1(GAL1)多克隆抗体(异硫氰酸荧光素标记) 产品包装(模拟)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对GAL1的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别GAL1。

用法

免疫印迹:0.2-2µg/mL;1:250-2500
免疫组织化学:5-20µg/mL;1:25-100
免疫细胞化学:5-20µg/mL;1:25-100
最佳稀释倍数最终由用户决定。

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPA321Hu01 半乳糖凝集素1(GAL1)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA321Hu01 半乳糖凝集素1(GAL1)多克隆抗体 WB; IHC; ICC; IP.
FAA321Hu01 抗半乳糖凝集素1(GAL1)多克隆抗体 Flow cytometry.
LAA321Hu71 半乳糖凝集素1(GAL1)多克隆抗体(生物素标记) WB; IHC; ICC.
LAA321Hu81 半乳糖凝集素1(GAL1)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
MAA321Hu22 半乳糖凝集素1(GAL1)单克隆抗体 WB; IHC; ICC; IP.
MEA321Hu 半乳糖凝集素1(GAL1)检测试剂盒(酶联免疫吸附试验法,小样本) Enzyme-linked immunosorbent assay for Antigen Detection.
SEA321Hu 半乳糖凝集素1(GAL1)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA321Hu 半乳糖凝集素1(GAL1)检测试剂盒(化学发光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
KSA321Hu01 半乳糖凝集素1(GAL1)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
International Journal of Oncology Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: Regulatory roles of cell surface glycans [Pubmed:24589677]
Clinica Chimica Acta Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population [Pubmed:25578395]
Journal of Perinatal Medicine Cord blood galectin-1 and-3 concentrations in term pregnancies with normal restricted and increased fetal growth [PubMed: 24717333]
Biomaterials Noninvasive small-animal imaging of galectin-1 upregulation for predicting tumor resistance to radiotherapy [Pubmed:29272764]
Advances in Experimental Medicine and Biology Molecules of Damage-Associated Patterns in Bronchoalveolar Lavage Fluid and Serum in Chronic Obstructive Pulmonary Disease [Pubmed:29429028]
留言咨询